Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

07/02/2018 Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension 11/01/2018 Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements 25/10/2016 Core Outcome Set-STAndards for Reporting: The COS-STAR Statement 22/06/2016 Medical abortion reporting of efficacy: the MARE guidelines. 22/03/2016 Standardized outcomes reporting in metabolic and bariatric surgery 18/03/2016 Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers 04/03/2016 Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT 08/09/2015 Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement 11/02/2015 Reporting outcomes of back pain trials: a modified Delphi study 28/01/2015 Common data elements for posttraumatic stress disorder research

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More